These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26260888)

  • 1. Decoupled association between (18)F-FDG and (18)F-FDOPA uptake in a carcinoid of the thymus.
    Chiaravalloti A; Schillaci O
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):139-40. PubMed ID: 26260888
    [No Abstract]   [Full Text] [Related]  

  • 2. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    Montravers F; Grahek D; Kerrou K; Ruszniewski P; de Beco V; Aide N; Gutman F; Grangé JD; Lotz JP; Talbot JN
    J Nucl Med; 2006 Sep; 47(9):1455-62. PubMed ID: 16954553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1.
    Abe T; Sato M; Okumura T; Shioyama Y; Kiyoshima M; Asato Y; Saito H; Iijima T; Amemiya R; Nagai H
    Clin Nucl Med; 2008 Nov; 33(11):778-9. PubMed ID: 18936612
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography with FDG to show thymic carcinoid.
    Groves AM; Mohan HK; Wegner EA; Hain SF; Bingham JB; Clarke SE
    AJR Am J Roentgenol; 2004 Feb; 182(2):511-3. PubMed ID: 14736691
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
    Kadowaki T; Yano S; Araki K; Tokushima T; Morioka N
    Thorax; 2011 Apr; 66(4):361-2. PubMed ID: 21075777
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymic carcinoid mimicking mediastinal lymphoma on
    Liu H; Liu L; Chen Y
    J Nucl Cardiol; 2021 Jun; 28(3):1193-1195. PubMed ID: 32236838
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
    Fiebrich HB; Brouwers AH; Koopmans KP; de Vries EG
    Eur J Cancer; 2009 Sep; 45(13):2312-5. PubMed ID: 19477116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Santhanam P; Taïeb D
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
    Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
    Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better discrimination of the nature of the synchronous pulmonary nodules with different morpho-metabolic characteristics by
    Garcia JR; Alvarez-Moro FJ; Soler M; Mourelo S; Bassa P; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):110-111. PubMed ID: 31918977
    [No Abstract]   [Full Text] [Related]  

  • 17. F-18 FDG positron emission tomography demonstration of pulmonary carcinoid.
    Jain M; Yung E; Trow T; Katz DS
    Clin Nucl Med; 2004 Jun; 29(6):370-1. PubMed ID: 15166885
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography].
    Gomard-Mennesson E; Sève P; De La Roche E; Collardeau-Frachon S; Lombard-Bohas C; Broussolle C
    Rev Med Interne; 2008 Sep; 29(9):751-3. PubMed ID: 18304700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.